Research
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania
-
* Corresponding author: Abdunoor M Kabanywanyi amulokozi@ihi.or.tz
1 Ifakara Health Institute, P.O. Box 78373, Kiko Avenue, Old Bagamoyo Road, Mikocheni, Dar es Salaam, Tanzania
2 Swiss Tropical Institute, Socinstrasse 57, Basel, CH-4056, Switzerland
3 Novartis Pharma AG, Lichtstrasse 35, Basel, CH-4056, Switzerland
4 Novartis Pharma (EACA), Hospital Road, Upper Hill, Nairobi, P.O. Box 46057 - 00100 GPO, Kenya
Malaria Journal 2010, 9:48 doi:10.1186/1475-2875-9-48
Published: 11 February 2010Additional files
Additional file 1:
Questionnaire. COA566A2422/ALIVE: A community-based study to assess the impact of Coartem (ALu) when used as national policy first-line treatment on malaria mortality and morbidity in Tanzania
Format: DOC Size: 108KB Download file
This file can be viewed with: Microsoft Word Viewer
